NASDAQ: ADIL
Adial Pharmaceuticals Inc Stock Ownership - Who owns Adial Pharmaceuticals?

Insider buying vs selling

Have Adial Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Coastlands Capital LP10% Owner2026-07-161,233$2.75
$3.39kBuy
Coastlands Capital LP10% Owner2026-07-142,000$2.65
$5.30kBuy
Coastlands Capital LP10% Owner2026-07-101,700$2.70
$4.59kBuy
Coastlands Capital LP10% Owner2026-07-0910,053$2.79
$28.05kBuy
Coastlands Capital LP10% Owner2026-06-2925,000$2.60
$65.00kBuy

1 of 1

ADIL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADIL insiders and whales buy or sell their stock.

ADIL Shareholders

What type of owners hold Adial Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
William B. Stilley Iii53.08%1,393,920$8.22MInsider
Bankole A. Johnson33.24%872,720$5.15MInsider
James W. Newman Jr.16.71%438,742$2.59MInsider
Coastlands Capital LP14.79%388,308$2.29MInsider
Matt Davidson11.40%299,414$1.77MInsider
Joseph Truluck10.10%265,139$1.56MInsider
Robertson H. Gilliland4.52%118,609$699.79kInsider
Cary J. Claiborne1.54%40,417$238.46kInsider
Tony Goodman1.01%26,523$156.49kInsider
Vinay Shah0.66%17,325$102.22kInsider

1 of 3

ADIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADIL0.00%100.00%Net BuyingNet Buying
CMMB0.00%2.89%Net BuyingNet Buying
CTXR0.00%2.06%
PLRZ0.01%5.29%Net Selling
TPST0.00%100.00%Net Buying

Adial Pharmaceuticals Stock Ownership FAQ

Who owns Adial Pharmaceuticals?

Adial Pharmaceuticals (NASDAQ: ADIL) is owned by 0.01% institutional shareholders, 147.52% Adial Pharmaceuticals insiders, and 0.00% retail investors. William B. Stilley Iii is the largest individual Adial Pharmaceuticals shareholder, owning 1.39M shares representing 53.08% of the company. William B. Stilley Iii's Adial Pharmaceuticals shares are currently valued at $8.66M.

If you're new to stock investing, here's how to buy Adial Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.